These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 29993298)

  • 1. Circadian rhythms may not influence the outcomes of thrombolysis in patients with ischemic stroke: A study from China.
    Ding J; Bai Z; Zhou D; Li X; Rajah GB; Ding Y; Han J; Ji X; Meng R
    Chronobiol Int; 2018 Oct; 35(11):1533-1542. PubMed ID: 29993298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke.
    Clark WM; Wissman S; Albers GW; Jhamandas JH; Madden KP; Hamilton S
    JAMA; 1999 Dec; 282(21):2019-26. PubMed ID: 10591384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circadian Rhythm and Risk of Hemorrhagic Transformation after Acute Ischemic Stroke Treated with Intravenous Thrombolysis - A Systematic Review.
    Stan A; Dragos H; Strilciuc S; Ilut S; Vacaras V; Cozma A; Panaitescu PS; Stan H; Muresanu DF
    CNS Neurol Disord Drug Targets; 2023; 22(10):1493-1506. PubMed ID: 36200200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonatrial Fibrillation was Associated With Early Neurological Improvement After Intravenous Thrombolysis With rt-PA in Patients With Acute Ischemic Stroke.
    Liu J; Huang J; Xu H; Dai H
    Neurologist; 2020 Mar; 25(2):28-32. PubMed ID: 32132497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utilization of intravenous thrombolysis in 3-4.5 hours: analysis of the Minnesota stroke registry.
    Tekle WG; Chaudhry SA; Hassan AE; Peacock JM; Lakshminarayan K; Tsai A; Luepker R; Anderson DC; Qureshi AI
    Cerebrovasc Dis; 2012; 34(5-6):400-5. PubMed ID: 23221276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the implementation of a 24-hr stroke thrombolysis emergency treatment for patients with acute ischaemic stroke.
    Zhao J; Li X; Liang Y; Zhao L; Zhang X; Liu Y
    J Clin Nurs; 2018 May; 27(9-10):2161-2167. PubMed ID: 29345016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time-dependence of NIHSS in predicting functional outcome of patients with acute ischemic stroke treated with intravenous thrombolysis.
    Wu Z; Zeng M; Li C; Qiu H; Feng H; Xu X; Zhang H; Wu J
    Postgrad Med J; 2019 Apr; 95(1122):181-186. PubMed ID: 30975729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pharmacoeconomic assessment of recombinant tissue plasminogen activator therapy for acute ischemic stroke in a tertiary hospital in China.
    Yan X; Hu HT; Liu S; Sun YH; Gao X
    Neurol Res; 2015 Apr; 37(4):352-8. PubMed ID: 25297471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant tissue plasminogen activator (rt-PA) utilisation by rural clinicians in acute ischaemic stroke: an audit of current practice and clinical outcomes.
    Williams JM; Navin TJ; Jude MR; Levi CR
    Aust J Rural Health; 2013 Aug; 21(4):203-7. PubMed ID: 24033520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multimode Computed-Tomography-Guided Thrombolysis under a Prolonged Time Window in Acute Ischemic Stroke Patients with Atrial Fibrillation.
    Yang Y; Sun W; Li D; Li XY; Wang XT; Li SC; Zhao HJ; Zhang JB
    Int Heart J; 2019 Jul; 60(4):822-829. PubMed ID: 31257338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time of day, outcome, and response to thrombolytic therapy: the National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Trial experience.
    Rhoney DH; Coplin WM; Lin Y; Frankel M; Lyden PD; Levine SR
    J Stroke Cerebrovasc Dis; 2010 Jan; 19(1):40-8. PubMed ID: 20123226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MRI-based ultrafast protocol thrombolysis with rt-PA for acute ischemia stroke in 12-hour time window.
    Li YH; Li MH; Zhao JG; Wang W
    J Neuroimaging; 2011 Oct; 21(4):332-9. PubMed ID: 21121996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TESPI (Thrombolysis in Elderly Stroke Patients in Italy): a randomized controlled trial of alteplase (rt-PA) versus standard treatment in acute ischaemic stroke in patients aged more than 80 years where thrombolysis is initiated within three hours after stroke onset.
    Lorenzano S; Toni D;
    Int J Stroke; 2012 Apr; 7(3):250-7. PubMed ID: 22292526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous Thrombolysis Is Safe and Effective for the Cryptogenic Stroke in China: Data From the Thrombolysis Implementation and Monitor of Acute Ischemic Stroke in China (TIMS-China).
    Fan Y; Liao X; Pan Y; Dong K; Wang Y; Wang Y;
    J Stroke Cerebrovasc Dis; 2019 Jan; 28(1):220-226. PubMed ID: 30366863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of acute kidney injury on in-hospital mortality in acute ischemic stroke patients undergoing intravenous thrombolysis.
    Gadalean F; Simu M; Parv F; Vorovenci R; Tudor R; Schiller A; Timar R; Petrica L; Velciov S; Gluhovschi C; Bob F; Mihaescu A; Timar B; Spasovski G; Ivan V
    PLoS One; 2017; 12(10):e0185589. PubMed ID: 29040276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Therapeutic Effect of Recombinant Tissue Plasminogen Activator by Treatment Time after Onset of Acute Ischemic Stroke.
    Wang HR; Chen M; Wang FL; Dai LH; Fei AH; Liu JF; Li HJ; Shen S; Liu M; Pan SM
    Sci Rep; 2015 Jul; 5():11743. PubMed ID: 26206308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of intravenous thrombolytic therapy for acute ischemic stroke with an integrated acute stroke referral network: initial experience of a community-based hospital in a developing country.
    Muengtaweepongsa S; Dharmasaroja P; Kummark U
    J Stroke Cerebrovasc Dis; 2012 Jan; 21(1):42-6. PubMed ID: 22225863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and feasibility of intravenous rt-PA in the Emergency Department without a neurologist-based stroke unit: an observational study.
    Tampieri A; Giovannini E; Rusconi AM; Cristoni L; Bendanti D; Cenni P; Lenzi T
    Intern Emerg Med; 2015 Mar; 10(2):181-92. PubMed ID: 25430677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue plasminogen activator (rt-PA) in acute ischemic stroke: Outcomes associated with ambulation.
    Lawson TR; Brown IE; Westerkam DL; Blackhurst DW; Sternberg S; Leacock R; Nathaniel TI
    Restor Neurol Neurosci; 2015; 33(3):301-8. PubMed ID: 25698111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results of intravenous thrombolysis within 4.5 to 6 hours and updated results within 3 to 4.5 hours of onset of acute ischemic stroke recorded in the Safe Implementation of Treatment in Stroke International Stroke Thrombolysis Register (SITS-ISTR): an observational study.
    Ahmed N; Kellert L; Lees KR; Mikulik R; Tatlisumak T; Toni D;
    JAMA Neurol; 2013 Jul; 70(7):837-44. PubMed ID: 23689267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.